Thursday, May 17, 2012
Onyx Pharmaceuticals CEO Tony Coles headlines SF Business Times Biotech Forum — June 14
The event begins with registration at 7:30 a.m. Thursday, June 14, at the Hilton San Francisco Union Square, 333 O'Farrell St.
Coles will be interviewed on stage by San Francisco Business Times biotech reporter Ron Leuty before joining a panel of Bay Area biotech industry experts. In addition to Coles, the panel will feature:
• Gideon Bollag, senior vice president for research, Plexxikon;
• Lissa Goldenstein, president and CEO, Auxogyn;
• Craig Muir, partner, Third Rock Ventures; and
• Glenn Oclassen, president and CEO, Transcept Pharmaceuticals.
Additionally, the event will feature presentations from three up-and-coming Bay Area life sciences companies -- Avalanche Biotechnologies, Organ-i and Neuraltus Pharmaceuticals -- about their businesses and the big scientific problems they are trying to solve.
Christie Smith, principal and West region life sciences leader at Deloitte Consulting LLP, will give opening remarks.
To order tickets for the event, call or email Jacquie Bischoff at 415-288-4972 or firstname.lastname@example.org. Tickets cost $70 per person or $750 for a table of 10.